Pfizer Inc.
Explore Pfizer Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Pfizer Inc.
Explore Pfizer Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2022 Revenue
$100.3B
▲ 23.4% vs FY2021 ($81.3B)
Source: Annual report / company filing
Pfizer Inc. reported $100.3B in revenue for fiscal year 2022. This represents a growth of 23.4% compared to the 2021 figure of $81.3B. In 2023, revenue declined to $58.5B.
Revenue peaked at 100.3 billion dollars in 2022, up 23.4%, the highest single-year total in pharmaceutical history as Comirnaty and the Paxlovid antiviral together added roughly 57 billion.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $62.6B | — | -1.6% |
| FY2024 | $63.6B | $8.0B | +8.7% |
| FY2023 | $58.5B | — | -41.7% |
| FY2022 | $100.3B | — | +23.4% |
| FY2021 | $81.3B | — | +94.0% |
| FY2020 | $41.9B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.